Literature DB >> 18570337

Differential effect of materials for surface hemostasis on red blood cell morphology.

Carr J Smith1, John N Vournakis, Marina Demcheva, Thomas H Fischer.   

Abstract

The design of devices for surface (topical) hemostasis has been based on maximizing activation of platelets and accelerating coagulation pathways. The studies reported herein examine another aspect of blood contact with topical hemostasis materials, i.e., surface binding of red blood cells (RBCs) and related alterations in RBC morphology. Whole blood was allowed to contact poly-N-acetyl glucosamine (pGlcNAc) containing materials: pGlcNAc nanofibers with parallel polymer alignment (beta-pGlcNAc), chitin, and chitosan. The effect on RBC morphology and function via contact with the artificial surfaces on the cell's morphology was examined with scanning and transmission electron microscopy (TEM). beta-pGlcNAc was found to densely bind RBCs and induce a stomatocytic-like morphology. Chitin and chitosan also bound RBCs, but with approximately 10-fold lower levels and with less distinct general morphologies. beta-pGlcNAc is thus unique in the nature of its interaction with RBCs. These studies indicate that the differential ability of various materials to bind and alter the morphology of RBCs at the artificial surface interface with blood is an important consideration in the design of devices for surface hemostasis. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18570337     DOI: 10.1002/jemt.20612

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  6 in total

1.  Poly-N-acetylglucosamine fibers amplify the effectiveness of recombinant factor VIIA on clot formation in hemophilia B canine blood.

Authors:  Thomas H Fischer; Timothy C Nichols; Christopher M Scull; Carr J Smith; Marina Demcheva
Journal:  J Trauma       Date:  2011-08

2.  Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro study.

Authors:  Anja Kaeberich; Iris Reindl; Uwe Raaz; Lars Maegdefessel; Alexander Vogt; Torsten Linde; Ulrich Steinseifer; Elisabeth Perzborn; Baerbel Hauroeder; Michael Buerke; Karl Werdan; Axel Schlitt
Journal:  J Thromb Thrombolysis       Date:  2011-11       Impact factor: 2.300

3.  The design and testing of a dual fiber textile matrix for accelerating surface hemostasis.

Authors:  Thomas H Fischer; John N Vournakis; James E Manning; Shane L McCurdy; Preston B Rich; Timothy C Nichols; Christopher M Scull; Marian G McCord; Joseph A Decorta; Peter C Johnson; Carr J Smith
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-10       Impact factor: 3.368

Review 4.  Chitosan modification and pharmaceutical/biomedical applications.

Authors:  Jiali Zhang; Wenshui Xia; Ping Liu; Qinyuan Cheng; Talba Tahirou; Wenxiu Gu; Bo Li
Journal:  Mar Drugs       Date:  2010-06-25       Impact factor: 5.118

5.  Peritoneal adhesion prevention with a biodegradable and injectable N,O-carboxymethyl chitosan-aldehyde hyaluronic acid hydrogel in a rat repeated-injury model.

Authors:  Linjiang Song; Ling Li; Tao He; Ning Wang; Suleixin Yang; Xi Yang; Yan Zeng; Wenli Zhang; Li Yang; Qinjie Wu; Changyang Gong
Journal:  Sci Rep       Date:  2016-11-21       Impact factor: 4.379

6.  Efficacy and Safety of Novel Beta-Chitin Patches as Haemostat in Rat Vascular and Neurosurgical Model.

Authors:  Ahad Sabab; Rajan Sundaresan Vediappan; John Finnie; C John McAdam; Alistair Jukes; Sarah Vreugde; Peter-John Wormald
Journal:  Front Surg       Date:  2022-04-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.